{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:08:22Z","timestamp":1761894502324},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1157\/13100563","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T08:26:39Z","timestamp":1176366399000},"page":"458-462","source":"Crossref","is-referenced-by-count":16,"title":["Utilidad del rituximab en el tratamiento de pacientes con enfermedades sist\u00e9micas autoinmunitarias"],"prefix":"10.1016","volume":"128","author":[{"given":"Francisco Jos\u00e9","family":"Garc\u00eda Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Oca\u00f1a Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Gonz\u00e1lez Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Garrido Rasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Colorado Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Castillo Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"S\u00e1nchez Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13100563_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.bor.0000172798.26249.fc","article-title":"Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future","volume":"17","author":"Sfikakis","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1157\/13100563_bib2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference","volume":"37","author":"Jennete","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib6","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.20858","article-title":"Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1078\/0171-2985-00200","article-title":"Effective B cell depletion with rituximab in the treatment of autoimmune diseases","volume":"206","author":"Kneitz","year":"2002","journal-title":"Immunobiology"},{"key":"10.1157\/13100563_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1999.tb01310.x","article-title":"The central and multiple roles of B cells in lupus pathogenesis","volume":"169","author":"Chan","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1157\/13100563_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autrev.2005.05.006","article-title":"Rituximab: a promising therapy in systemic lupus erythematosus","volume":"5","author":"Thatayatikom","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1157\/13100563_bib11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","article-title":"Rituximab therapy and autoimmune disorders. Prospects for anti-B cell therapy","volume":"48","author":"Silverman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1157\/13070854","article-title":"S\u00edndrome de Sj\u00f6gren. Nuevas perspectivas terap\u00e9uticas","volume":"124","author":"Ramos Casals","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13100563_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1157\/13067545","article-title":"Perspectivas terap\u00e9uticas en el lupus eritematoso sist\u00e9mico","volume":"123","author":"Cervera","year":"2004","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 12","key":"10.1157\/13100563_bib14","first-page":"99","article-title":"A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia","volume":"27","author":"Saleh","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1157\/13100563_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.1081","article-title":"Refractory autoimmune thrombocytopenic purpura treatment with Rituximab","volume":"67","author":"Patel","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1157\/13100563_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1600-0609.2002.02686.x","article-title":"Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study","volume":"69","author":"Giagounidis","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1157\/13100563_bib17","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener\u2019s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib18","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study of B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib19","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1157\/13100563_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/03009740410010227","article-title":"Biopsy-verified response of severe lupus nephritis to treatment with rituximab (antiCD20-monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone","volume":"33","author":"Van Vollenhoven","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1157\/13100563_bib21","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1157\/13100563_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/rheumatology\/keh443","article-title":"Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab","volume":"44","author":"Tokunaga","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1157\/13100563_bib23","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.21351","article-title":"B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus","volume":"52","author":"Marks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13100563_bib25","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kei080","article-title":"B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients","volume":"44","author":"Leandro","year":"2005","journal-title":"Rheumatology"},{"key":"10.1157\/13100563_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13100563_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","article-title":"Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab","volume":"257","author":"Eriksson","year":"2005","journal-title":"J Intern Med"},{"key":"10.1157\/13100563_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/02813430510015269","article-title":"Anti-CD20 therapy of treatment-resistant Wegener\u2019s granulomatosis: favourable buttemporary response","volume":"34","author":"Omdal","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1157\/13100563_bib29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of rituximab in Wegener\u2019s granulomatosis with refractory granulomatous manifestations","volume":"65","author":"Aries","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13100563_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13100563_bib31","first-page":"23","article-title":"Experience with rituximab in the treatment of systemic lupus erythematosus","volume":"2","author":"Garc\u00eda Hern\u00e1ndez","year":"2006","journal-title":"Reumatol Clin"},{"key":"10.1157\/13100563_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5414\/CNP64073","article-title":"Failure of rituximab to treat a lupus flare-up with nephritis","volume":"64","author":"Lambotte","year":"2005","journal-title":"Clin Nephrol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307726234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307726234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T09:25:56Z","timestamp":1546939556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307726234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0025775307726234"],"URL":"https:\/\/doi.org\/10.1157\/13100563","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}